Cargando…
Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
Autores principales: | Cheung, BMY, Fei, Y, Tsoi, MF |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312648/ https://www.ncbi.nlm.nih.gov/pubmed/32612700 http://dx.doi.org/10.15420/ecr.2020.15.1.PO17 |
Ejemplares similares
-
Posters from the 24th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy: Best Poster Award – First Prize: Network Meta-analysis to Determine the Optimal Level of Systolic Blood Pressure for Hypertensive Patients
por: Cheung, BMY, et al.
Publicado: (2020) -
Blood Lead Level and Hypertension Risk in the United States National Health Nutrition and Examination Survey (NHANES) 1999–2016
por: Cheung, BMY, et al.
Publicado: (2020) -
Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis
por: Fei, Yue, et al.
Publicado: (2019) -
25th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy
por: Tan, Jack Wei Chieh
Publicado: (2021) -
Best Poster Award – Third Prize: The Perilousness of Antidepressant Drugs in a Real-world Cohort of Patients with Acute Coronary Syndrome
por: Denegri, A, et al.
Publicado: (2020)